Fibronectin, plasminogen activator inhibitor type 1 (PAI-1) and uterine artery Doppler velocimetry as markers of preeclampsia.

Multicenter screening for pre‐eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation

Aris T. Papageorghiou, C. K. H. Yu, Randy Bindra et al. · Ultrasound in Obstetrics and Gynecology · 2001 · 542 citations · Full text

Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction

M. Parra, Ramón Rodrigo, P. Barja et al. · American Journal of Obstetrics and Gynecology · 2005 · 140 citations · Full text

Hypertension, Gestational Hypertension, Physiology +11

Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels

Seyfettin Uludağ, Vildan Ocak, Necati Tolun · Acta Obstetricia Et Gynecologica Scandinavica · 2003 · 137 citations · Full text

Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre‐eclampsia

Srdjan Djurovic, Torun Clausen, Ragnhild Wergeland et al. · BJOG An International Journal of Obstetrics & Gynaecology · 2002 · 82 citations · Full text

Pregnancy outcome and fibrinolytic, endothelial and coagulation markers in women undergoing uterine artery Doppler screening at 23 weeks

Beverley J. Hunt, Hannah Missfelder‐Lobos, M. Parra‐Cordero et al. · Journal of Thrombosis and Haemostasis · 2009 · 41 citations

Thrombosis, Coagulation Markers, Postpartum Hemorrhage +13